Back to top
more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

96.59
692,880

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

PerkinElmer (PKI) to Post Q1 Earnings: What's in the Cards?

by Zacks Equity Research

PerkinElmer's (PKI) first-quarter results are likely to reflect strong performance at Diagnostics segment.

Sonos, Dollar General, PerkinElmer, PRA Health Sciences and Hologic highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Sonos, Dollar General, PerkinElmer, PRA Health Sciences and Hologic highlighted as Zacks Bull and Bear of the Day

Can PerkinElmer (PKI) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 MedTech Subsectors Poised to Perform Impressively in Q121

by Zacks Equity Research

Here we discuss three MedTech subsectors, which encourage us with their consistency through the pandemic year and are likely to have continued with their winning streak in Q121.

Sriparna Ghosal headshot

Buy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021

by Sriparna Ghosal

Let's take a look at the three MedTech stocks performing well lately, banking on a host of impressive developments.

PerkinElmer's (PKI) Horizon Discovery Broadens Portfolio

by Zacks Equity Research

PerkinElmer's (PKI) CRISPRi will help scientists get a firmer foothold in the biological pathways, processes and pathologies of disease.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

by Zacks Equity Research

PerkinElmer (PKI) continues to gain traction for solid product portfolio and improving margins. However, forex is a woe

PerkinElmer (PKI) Boosts Testing Portfolio With New Solutions

by Zacks Equity Research

PerkinElmer's (PKI) introduction of two comprehensive solutions is likely to strengthen its COVID-19 testing portfolio further.

Why Is PerkinElmer (PKI) Down 9.6% Since Last Earnings Report?

by Zacks Equity Research

PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is PerkinElmer (PKI) Stock a Good Pick for Value Investors?

by Zacks Equity Research

Is PerkinElmer (PKI) a great pick from the value investor's perspective right now? Read on to know more.

Zimmer Biomet (ZBH) Beats on Q4 Earnings, to Rejig Portfolio

by Zacks Equity Research

Zimmer Biomet (ZBH) states that continued pressure from the COVID-19 pandemic slowed the recovery of elective procedures in the fourth quarter.

Becton Dickinson (BDX) Earnings Surpass Estimates in Q1

by Zacks Equity Research

Each of Becton Dickinson's (BDX) core units witnesses strong revenue growth in the fiscal first quarter.

Change Healthcare (CHNG) Q3 Earnings Top Estimates, Up Y/Y

by Zacks Equity Research

Change Healthcare's (CHNG) fiscal third-quarter results benefit from solid performance in the Network Solutions segment.

Baxter (BAX) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Baxter's (BAX) fourth-quarter results reflect robust performance across five of its business units.

AmerisourceBergen (ABC) Q1 Earnings & Revenues Beat Estimates

by Zacks Equity Research

AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth.

The Cooper Companies (COO) Unit Gets a Boost From New Buyout

by Zacks Equity Research

The Cooper Companies (COO) arm's buyout drives its growing portfolio of medical products, which revolves around clinic and practice-based women's healthcare

PerkinElmer (PKI) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

PerkinElmer's (PKI) fourth-quarter results benefit from strong segmental performance.

PerkinElmer (PKI) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

PerkinElmer (PKI) delivered earnings and revenue surprises of 9.70% and 7.69%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Why You Should Add AngioDynamics (ANGO) to Your Portfolio

by Zacks Equity Research

Investor confidence is high in AngioDynamics (ANGO) stock, courtesy of its solid prospects.

Abiomed (ABMD) Posts Upbeat Impella SmartAssist Study Results

by Zacks Equity Research

The study proves that Abiomed's (ABMD) Impella 5.5 with SmartAssist delivers successful clinical and device outcomes.

Dynatrace (DT) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Dynatrace's (DT) fiscal third-quarter 2021 earnings are likely to have gained from robust adoption of its APM solutions, expanding clientele and strong recurring-revenue base.

Zacks.com featured highlights include: Crown Holdings, Rockwell Automation, PerkinElmer, KeyCorp and ONEOK

by Zacks Equity Research

Zacks.com featured highlights include: Crown Holdings, Rockwell Automation, PerkinElmer, KeyCorp and ONEOK

Swayta Shah headshot

5 Attractive Sales Growth Stocks to Power Your Portfolio

by Swayta Shah

Robust sales growth is the key to survival in today's fast changing and highly competitive operating backdrop. Let's check Crown Holdings (CCK), Rockwell Automation (ROK), PerkinElmer (PKI), KeyCorp (KEY) & ONEOK (OKE) as these might witness solid sales growth.

PerkinElmer (PKI) to Post Q4 Earnings: What's in the Cards?

by Zacks Equity Research

PerkinElmer's (PKI) fourth-quarter results are likely to reflect strong performance at Diagnostics segment.

Top Ranked Growth Stocks to Buy for January 27th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 27th